论文部分内容阅读
目的探讨阿奇霉素治疗小儿支原体肺炎的临床效果,以及对其药物的安全分析。方法选取过去诊治过的330例患有支原体肺炎的患儿,将其随机分成两组,A组采用阿奇霉素进行治疗,B组使用乳酸红霉素进行治疗,将两组的效果进行分析,包括治疗时间、肝功能以及不良反应。结果 A组的疗效明显的高于B组,P<0.05,临床症状以及咳嗽好转的情况进行对比以后,其差异情况具有统计学意义,P<0.05。结论治疗小儿支原体肺炎效果明显的为阿奇霉素,其效果好,治疗时间短,且不良反应以及对肝脏功能的危害也很小,此药为安全性药物。
Objective To investigate the clinical efficacy of azithromycin in the treatment of Mycoplasma pneumoniae in children and the safety analysis of its drugs. Methods A total of 330 children with mycoplasma pneumonia who were diagnosed and treated in the past were randomly divided into two groups. Group A was treated with azithromycin and group B was treated with erythromycin lactate. The effects of two groups were analyzed including treatment Time, liver function and adverse reactions. Results The efficacy of group A was significantly higher than that of group B, P <0.05, clinical symptoms and cough improved after the comparison, the difference was statistically significant, P <0.05. Conclusion The treatment of mycoplasma pneumonia in children with obvious azithromycin, its effect is good, the treatment time is short, and adverse reactions and the damage to liver function is also very small, this drug is a safety drug.